EORTC at ESTRO37 Congress

Joint ESTRO-EORTC interdisciplinary Session

Tuesday, April 24th, 09:15-10:30, Room 116

On the occasion of ESTRO 37 congress held in Barcelona from 20 to 24 April, ESTRO and EORTC have compiled a session to explore current and further future cooperation between the two organisations. The session will discuss the state of the art and future perspectives of clinical research in radiation oncology.

The focus will be on three main topics:

Oligometastatic disease:

  • Is oligometastatic disease a distinct biological entity?
  • Prospective trials vs registry trial in this disease
  • Presentation of ESTRO-EORTC Oligocare project

Chemotherapy-beam combinations:

  • General principles of association
  • Challenges in conducting chemo-radiotherapy trials
  • PARP inhibition and radiotherapy

and particle therapy:

  • Current developments in Europe
  • Discussion on the lack of level I evidence supporting this costly treatment modality and how this should be corrected by performing appropriate clinical research

More info about the joint session here.

EORTC Abstracts at ESTRO 37

EORTC will also be presenting a number of studies at the congress:

  1. ORAL PRESENTATION: Phase-II parallel non-randomized/observation study (EORTC 22042-26042) for non-benign meningiomas
    D.C. Weber, C. Ares, S. Villa, S.M. Peerdeman, L. Renard, B.G. Baumert, A. Lucas, J.J. Stelmes, S. Collette, R. Miralbell OC-0589
    Presented at 16h35 in the Auditorium on Monday 23 April 2018
  2. POSTER PRESENTATION: PV-0200: Benchmark Case results from the EORTC Lungtech trial of SBRT for patients with centrally NSCLC
    M. Lambrecht, E. Clementel, J. Sonke, U. Nestle, S. Adebahr, M. Guckenberger, D. Weber, C. Hurkmans.
    Presented Saturday, April 21st, 16:15 – 17:30, Poster area, candidate for best poster in the track.
  3. POSTER PRESENTATION: Quality assurance of radiotherapy in the EORTC 1420 Best-of trial. Preliminary results
    J.J. Stelmes (Belgium), E. Clementel, J. Kaźmierska, M. Ozsahin, M. Tomsej, L. Viellevigne, V. Gregoire, C. Hurkmans, N. Andratschke, D.C. Weber PO-0708

Find the Abstracts Book of ESTRO 37 here.

Back to news list

Related News

  • Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group

  • Clinical Trials Day 2024: a Q&A on pragmatic clinical trials

  • EORTC/EMA workshop suggests an international way forward for treatment optimisation studies

  • EORTC’s Participation at the ESTRO Congress 2024

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023